Immuron (IMRN) Cost of Revenue (2016 - 2024)
Immuron has reported Cost of Revenue over the past 9 years, most recently at -$874530928.1 billion for Q4 2024.
- For Q4 2024, Cost of Revenue fell 1.7328814144698834e+16% year-over-year to -$874530928.1 billion; the TTM value through Dec 2024 reached -$874530928.1 billion, down 436931185995956.0%, while the annual FY2025 figure was $312370.5, 69.59% down from the prior year.
- Cost of Revenue for Q4 2024 was -$874530928.1 billion at Immuron, down from $5046.7 in the prior quarter.
- Over five years, Cost of Revenue peaked at $505.7 million in Q4 2021 and troughed at -$874530928.1 billion in Q4 2024.
- A 5-year average of -$109316365.9 billion and a median of $19690.2 in 2023 define the central range for Cost of Revenue.
- Biggest five-year swings in Cost of Revenue: soared 5542120496576.42% in 2021 and later tumbled 1.7328814144698834e+16% in 2024.
- Year by year, Cost of Revenue stood at $0.01 in 2020, then soared by 5542120496576.42% to $505.7 million in 2021, then tumbled by 99.97% to $155726.0 in 2022, then crashed by 96.76% to $5046.7 in 2023, then tumbled by 1.7328814144698834e+16% to -$874530928.1 billion in 2024.
- Business Quant data shows Cost of Revenue for IMRN at -$874530928.1 billion in Q4 2024, $5046.7 in Q4 2023, and $14310.9 in Q2 2023.